Industry
Prometheus Enters Oncology Market via Agreement With Rosetta Genomics
Prometheus Laboratories and Rosetta Genomics announced the execution of a license and collaboration agreement under which Rosetta grants Prometheus U.S. rights to three recently introduced, microRNA-based cancer diagnostic tests. More...20 Apr 2009
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
In Other News
Independent Market Research Ranks Sysmex in Hematology Instruments
Noninvasive Prenatal Genetic Screening Tests Are Safer
Lab21 Expands Microbiology Offering With Acquisition of Biotec
Nanogen Expands Partnership with HandyLab for IVD Testing
Innovative Biosensors Develops Rapid Diagnostics System With Progentech
Millipore Acquires Technology for Developing Antibodies
Novel Technologies Drive European IVD Cancer Sector
Beckman To Buy Diagnostics Business from Olympus for $800 Million
Prediabetes Screening Test Completed Within One Hour
IVD Sector Not Affected by Current Economic Conditions
Noninvasive Prenatal Blood Test To Predict Genetic Disorders
Sequenom Acquires SensiGen and Expands Molecular Diagnostics Portfolio
XDx Develops Blood Tests To Identify Lupus Biomarkers
Abbott To Offer New Approach to Pathogen Detection
Molecular Diagnostics Emerging Rapidly for Routine Patient Care
EGFR Companion Diagnostics Marketed in United States and Canada
Competitive Intelligence Can Help Healthcare Companies in Uncertain Times
Pulmonary Biomarker Surfactant Protein-B Is Used for Diagnosis
DxS and Amgen Collaborate on Companion Diagnostic for Vectibix
Laboratories Consolidate Clinical Chemistry and Immunoassay Analyzers
Dako To Develop Companion Diagnostic for Cancer Therapy
Noninvasive Procedure Improves Success Rate of IVF
Nanogen and the French Diagnostic Company Elitech Merge
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.